Clinical Trial Update: Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of buprenorphine/naloxone for heroin dependence conducted by the University of Colorado, Denver was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heroin Dependence
• Opioid Use Disorder

Drugs mentioned

• Buprenorphine/naloxone (buprenorphine/naloxone)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Heroin Dependence, Opioid-Related Disorders | Phase 2 | Status: WITHDRAWN